In ESCC and OSCC, through the engagement of integrin αvβ8, the COL1A2 chain promotes EMT by activating the FAK/MEK/ERK signaling pathway resulting in higher tumor cell aggressiveness [107,108]. Here, PTK2 is linked to neoplasm.